[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Myara et al., 2003 - Google Patents

Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients

Myara et al., 2003

View PDF @Full View
Document ID
10419563575363492694
Author
Myara I
Alamowitch C
Michel O
Heudes D
Bariety J
Guy‐Grand B
Chevalier J
Publication year
Publication venue
Obesity research

External Links

Snippet

Objective: To correlate the susceptibility of low‐(LDL) and very‐low‐density lipoprotein to oxidation in vitro and the concentrations of serum antibodies against malondialdehyde‐ modified LDL and plasma vitamin E with the anthropometric and laboratory characteristics of …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/573—Immunoassay; Biospecific binding assay for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Myara et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients
Sutherland et al. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat
Vessby et al. Oxidative stress and antioxidant status in type 1 diabetes mellitus
Handelman et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Diekman et al. Increased oxidizability of low-density lipoproteins in hypothyroidism
Block et al. Factors associated with oxidative stress in human populations
Kontush et al. α-Tocopherol as a Reductant for Cu (II) in Human Lipoproteins: TRIGGERING ROLE IN THE INITIATION OF LIPOPROTEIN OXIDATION (∗)
Camilletti et al. Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients
Sanchez-Quesada et al. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control
Moro et al. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre‐oxidative condition?
Beulens et al. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1
Badid et al. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer
Ziobro et al. Oxidative damages in erythrocytes of patients with metabolic syndrome
Yoshida et al. Vitamin E/Lipid Peroxide Ratio and Susceptibility of LDL to Oxidative Modification in Non–Insulin-Dependent Diabetes Mellitus
Brude et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers
Doi et al. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation
Rowicka et al. Oxidative and Antioxidative Status of Children with Celiac Disease Treated with a Gluten Free‐Diet
Raiszadeh et al. Serum paraoxonase activity before and after treatment of thyrotoxicosis
Julier et al. Susceptibility of low‐and high‐density lipoproteins from diabetic subjects to in vitro oxidative modification
Aoki et al. Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis
Bekpinar et al. Evaluation of nitrosative and oxidative stress in Behçet disease
Menke et al. Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1
Giannini et al. Effects of high‐dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus
Pereira et al. Antioxidant effect of simvastatin is not enhanced by its association with α-tocopherol in hypercholesterolemic patients
Kurosaki et al. Semiquantitative Analysis of Apolipoprotein A‐I Modified by Advanced Glycation End Products in Diabetes Mellitus